Literature DB >> 30099590

Cotranscriptional 3'-End Processing of T7 RNA Polymerase Transcripts by a Smaller HDV Ribozyme.

Arvin Akoopie1, Ulrich F Müller2.   

Abstract

In vitro run-off transcription by T7 RNA polymerase generates heterogeneous 3'-ends because the enzyme tends to add untemplated adenylates. To generate homogeneous 3'-termini, HDV ribozymes have been used widely. Their sequences are added to the 3'-terminus such that co-transcriptional self-cleavage generates homogeneous 3'-ends. A shorter HDV sequence that cleaves itself efficiently would be advantageous. Here we show that a recently discovered, small HDV ribozyme is a good alternative to the previously used HDV ribozyme. The new HDV ribozyme is more efficient in some sequence contexts, and less efficient in other sequence contexts than the previously used HDV ribozyme. The smaller size makes the new HDV ribozyme a good alternative for transcript 3'-end processing.

Keywords:  3′-Terminus; Co-transcriptional processing; HDV ribozyme; In vitro transcription

Mesh:

Substances:

Year:  2018        PMID: 30099590     DOI: 10.1007/s00239-018-9861-9

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  29 in total

1.  T7 RNA polymerase mediates fast promoter-independent extension of unstable nucleic acid complexes.

Authors:  Hani S Zaher; Peter J Unrau
Journal:  Biochemistry       Date:  2004-06-22       Impact factor: 3.162

2.  Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions.

Authors:  S P Rosenstein; M D Been
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

3.  New catalytic structures from an existing ribozyme.

Authors:  Edward A Curtis; David P Bartel
Journal:  Nat Struct Mol Biol       Date:  2005-11       Impact factor: 15.369

4.  Determination of hepatitis delta virus ribozyme N(-1) nucleobase and functional group specificity using internal competition kinetics.

Authors:  Daniel L Kellerman; Kandice S Simmons; Mayra Pedraza; Joseph A Piccirilli; Darrin M York; Michael E Harris
Journal:  Anal Biochem       Date:  2015-05-01       Impact factor: 3.365

5.  Cis-acting ribozymes for the production of RNA in vitro transcripts with defined 5' and 3' ends.

Authors:  Johanna M Avis; Graeme L Conn; Scott C Walker
Journal:  Methods Mol Biol       Date:  2012

6.  Identification of minimal HDV-like ribozymes with unique divalent metal ion dependence in the human microbiome.

Authors:  Nathan J Riccitelli; Eric Delwart; Andrej Lupták
Journal:  Biochemistry       Date:  2014-03-05       Impact factor: 3.162

7.  Widespread occurrence of self-cleaving ribozymes.

Authors:  Chiu-Ho T Webb; Nathan J Riccitelli; Dana J Ruminski; Andrej Lupták
Journal:  Science       Date:  2009-11-13       Impact factor: 47.728

8.  Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5' substrate sequence.

Authors:  Sohee Jeong; Jana Sefcikova; Rebecca A Tinsley; David Rueda; Nils G Walter
Journal:  Biochemistry       Date:  2003-07-01       Impact factor: 3.162

9.  RNA-catalysed nucleotide synthesis.

Authors:  P J Unrau; D P Bartel
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Controlling the direction of site-selectivity and regioselectivity in RNA ligation by Zn2+-dependent deoxyribozymes that use 2',3'-cyclic phosphate RNA substrates.

Authors:  Diana M Kost; Joseph P Gerdt; P I Pradeepkumar; Scott K Silverman
Journal:  Org Biomol Chem       Date:  2008-10-27       Impact factor: 3.876

View more
  2 in total

1.  A robust and versatile method for production and purification of large-scale RNA samples for structural biology.

Authors:  Hampus Karlsson; Lorenzo Baronti; Katja Petzold
Journal:  RNA       Date:  2020-04-30       Impact factor: 4.942

2.  A scalable system for the fast production of RNA with homogeneous terminal ends.

Authors:  Yuchen Chen; Yan Cheng; Jinzhong Lin
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.